Drug · DIN 02469626
SERTRALINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 17, 2018; first marketed January 17, 2018.
- Drug Identification Number (DIN)
- 02469626
- Company (DIN owner)
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Sertraline N06AB06
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SERTRALINE (SERTRALINE HYDROCHLORIDE) | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 7, 2017: NOC 20014Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named SERTRALINE
- DIN 02353520 · Marketed
- DIN 02353539 · Marketed
- DIN 02353547 · Marketed
- DIN 02386070 · Marketed
- DIN 02386089 · Marketed
- DIN 02386097 · Marketed
- DIN 02469634 · Marketed
- DIN 02469642 · Marketed
- DIN 02537249 · Marketed
- DIN 02537265 · Marketed
- DIN 02537281 · Marketed
- DIN 02284804 · Cancelled Post Market
- DIN 02284812 · Cancelled Post Market
- DIN 02284820 · Cancelled Post Market
- DIN 02303779 · Cancelled Post Market
- DIN 02303809 · Cancelled Post Market
- DIN 02303817 · Cancelled Post Market
- DIN 02342359 · Cancelled Pre Market
- DIN 02342367 · Cancelled Pre Market
- DIN 02342375 · Cancelled Pre Market